Analyze any comparative advantages and international trade opportunities.

Analyze any comparative advantages and international trade opportunities.

Purpose of Assignment

Students will develop cost curves on which firm behavior is based and will utilize these cost curves to determine the behavior of their chosen organization in the market served. Using the concept of comparative advantage, students analyze trade opportunities and use the model of supply and demand to explain factors that could affect demand, supply and prices. Students will determine various factors that could affect their organization’s total revenue and will recommend actions the firm could use to maximize their profit and their presence in the market served.

Assignment Steps

Scenario: You have been given the responsibility of working with your organization’s CEO to do a competitive market analysis of the potential success of one of their existing products.

Research an organization and a product produced by that organization in which an analysis can be conducted.

Write a 1,750-word analysis of the current market conditions facing your product, making sure you address the following topics:

Define the type of market in which your selected product will compete, along with an analysis of competitors and customers.
Analyze any comparative advantages and international trade opportunities.
Explain the factors that will affect demand, supply, and prices of that product.
Examine factors that will affect Total Revenue, including but not limited to:
Price elasticity of demand
Factors that influence productivity
Various measures of costs, including opportunity costs
Externalities and government public policy and their effect on marginal revenue and marginal cost
Recommend how your organization can maximize their profit-making potential and increase their presence within the market served by the product.

Cite a minimum of three peer-reviewed sources from the University Library.

Format your paper consistent with APA guidelines.

Tobacco addiction case study

Nick is a thirty-year-old Caucasian male who recently enrolled in your patient panel. He comes in today because he desires to “kick the habit” of tobacco use. He had tried to quit before and succeeded twice, only to start up again. He denies any health problems but has a strong family history of COPD and lung cancer. His father died of lung cancer three months ago, and he has been dreaming of him since then. He does not want to end up the same way.


Past medical history

The patient denies medical problems. He had a vasectomy four years age at his ex-wife’s request, no other surgeries. He has noticed a recurrent morning cough and increased production of mucus over the past two months or so.


Medications

– none


Allergies

– none


Stage of change

– contemplation


Diagnosis

– tobacco abuse and addiction


Patient education

Through the use of tobacco, nicotine is one of the most heavily used addictive substances and the leading preventable cause of disease, disability, and death in the United States (Brunton, Chabner, & Knollman, 2011). According to the Center for Disease Control and Prevention, cigarette smoking accounts for around one of every five deaths in the United States (Center for Disease Control and Prevention).

When a person is addicted to a substance, they have a compulsive urge to seek out and use the substance, even when they understand the harmful effects it can have (Brunton, Chabner, & Knollman, 2011). Tobacco products are addictive. With each inhalation of a cigarette the smoker pulls nicotine and other harmful substances into the lungs, where it is absorbed into the blood stream (Brunton, Chabner, & Knollman, 2011). Nicotine is shaped like the natural brain chemical acetylcholine. Acetylcholine is a chemical called a neurotransmitter; this carries messages between the brain cells or neurons (Brunton, Chabner, & Knollman, 2011). Theses brain cells or neurons have specialized proteins called receptors, into which specific neurotransmitters fit. Nicotine locks into acetylcholine receptors. Nicotine attaches to acetylcholine receptors that release a neurotransmitter called dopamine. Dopamine is released normally when a person experiences something pleasurable. Smoking causes neurons (brain cells) to release excess dopamine, which is the cause of feelings of pleasure when smoking (Brunton, Chabner, & Knollman, 2011). This effect wears off quickly, causing the smoker to get the urge to light up another cigarette for another dose of the drug (Brunton, Chabner, & Knollman, 2011).

Nicotine is the primary addictive component in tobacco, but it is not the only important ingredient (Brunton, Chabner, & Knollman, 2011). People who smoke have a reduction in the level of an enzyme called monoamine oxidase (MAO) in the brain and body. Lower levels of MAO in the brain may lead to higher dopamine levels and this leads to the reason people continue to smoke and continue to get the pleasurable effects from smoking (Brunton, Chabner, & Knollman, 2011).

Long-term use of nicotine products leads to addiction. The way nicotine is absorbed and metabolized by the body enhances its addictive potential (Brunton, Chabner, & Knollman, 2011). Each inhalation brings rapid distribution of nicotine to the brain, but it quickly disappears along with the pleasurable feelings. This triggers the smoker to seek that same pleasurable sensation throughout the day (Brunton, Chabner, & Knollman, 2011). Over the course of the day tolerance develops, requiring more frequent doses or higher doses to get the same effect. Nicotine, heroin, and cocaine have similar effects on the brain (Brunton, Chabner, & Knollman, 2011).

Many people who have a nicotine addiction are in denial. They may be social smokers, meaning they only smoke when out with friends, or they believe they can stop when they are ready (Center for Disease Control and Prevention, 2008). Recognizing the signs of addiction is important for the getting over the addiction. Common signs of addiction include requiring increased use of tobacco to get the same satisfaction, experiencing withdrawal when nicotine levels are low, having the desire to quit but not being able to, experiencing cravings and urges to smoke, and continuing to smoke despite being aware of the health risks (Center for Disease Control and Prevention, 2008).

The physical symptoms of nicotine addiction are caused by withdrawal. Withdrawal occurs because the brain can no longer naturally produce adequate levels of dopamine. Nicotine withdrawal symptoms include anxiety, frustration, irritability, depression, difficulty concentrating, increased appetite, and weight gain (Brunton, Chabner, & Knollman, 2011).

Some of the health risks associated with nicotine use include chronic obstructive lung disease (COPD), lung cancer, asthma, gum disease, mouth and esophageal cancer, heart disease, and stroke. The carcinogens in tobacco products cause abnormal cell growth that can develop into cancer (Brunton, Chabner, & Knollman, 2011).

Deciding to quit smoking is the first step toward becoming a non-smoker and better health (Center for Disease Control and Prevention). After quitting, the risk of stroke can be reduced to that of a non-smoker in as little as two years after quitting (Center for Disease Control and Prevention). Heart rate and blood pressure return to the non-smoker levels after only two hours of not smoking. The rate of heart disease related to smoking is decreased to fifty percent and the rate of lung cancer is substantially reduced (Center for Disease Control and Prevention).

Steps to nicotine abuse and addiction recovery that may help are to set a date to quit; this allows the person to get in the mindset to stop (Center for Disease Control and Prevention, 2008). Knowing the triggers that make the person want to smoke is another important factor. Some triggers commonly observed that increase the desire to smoke are after a meal, while driving, drinking alcohol, boredom, stress, coffee, and being around other people that smoke (Center for Disease Control and Prevention, 2008). Having a strong support system is another important factor in quitting. Informing the people around the smoker of the decision to quit may help to support the decision as well as holding the smoker accountable for the goal of quitting. It is easier to stop smoking if the people around support the effort to stop smoking (Center for Disease Control and Prevention, 2008).

If the smoker is thinking about quitting, or has made the decision to quit, there are several products to help in the process of quitting and prevent many of the withdrawal symptoms. Nicotine replacement is an alternative to stopping cold. Many people find it easier to use a replacement therapy such as the nicotine patch, inhaler, or nicotine gum. This may make the transition easier and more comfortable for the person trying to quit (Center for Disease Control and Prevention, 2008).

Tobacco dependence is a chronic disease that often requires repeated interventions and multiple attempts to quit. Effective treatments exist; however, that can significantly increase the rate of long-term abstinence. Counseling and medications are effective when used by themselves. The combination of counseling and medications, however, is more effective than either alone (Center for Disease Control and Prevention, 2008).


Products designed to help quit tobacco abuse and addiction


Bupropion SR

treatment should begin one to two weeks before the quit date. The starting dose for tobacco cessation is 150mg orally every morning for three days, then 150mg orally twice daily. This dosage should be continued for seven to twelve weeks. For long-term dosage, use of bupropion SR 150 mg for up to six months post-quit may be used (Center for Disease Control and Prevention, 2008).

Common side effects include insomnia and dry mouth. Insomnia may be addressed by taking the evening pill at least eight hours before bedtime, with at least eight hours between doses (Center for Disease Control and Prevention, 2008).


Nicotine gum

is available in both regular and flavored forms. The gum dosage is available in two milligrams and four milligram doses. Smokers should use at least one piece every one to two hours for the first six weeks (Center for Disease Control and Prevention, 2008). The gum should be used for up to twelve weeks with no more than twenty-four pieces to be used per day. Common side effects of the gum include mouth soreness, hiccups, dyspepsia, and jaw ache. These effects are generally mild and transient, often caused by the patient’s chewing technique (Center for Disease Control and Prevention, 2008). This can be alleviated by correct chewing techniques. The gum should be chewed slowly until taste emerges, then parked between the cheek and gum line to facilitate absorption. The gum should be slowly and intermittently chewed and parked for around thirty minutes or until taste dissipates from the gum (Center for Disease Control and Prevention, 2008).


Nicotine Inhalers-

A dose from the nicotine inhaler consists of a puff or inhalation. Each cartridge delivers a total of one milligram of nicotine over eighty inhalations (Center for Disease Control and Prevention, 2008). Recommended dosage is six to sixteen cartridges per day. Duration of the therapy is up to six months. Side effects include local irritation in the mouth and throat, coughing, and rhinitis. The severity of the irritation is mild and the frequency of symptoms decline with continuous use (Center for Disease Control and Prevention, 2008).


Nicotine lozenges

are available in two milligrams and four milligram doses (Center for Disease Control and Prevention, 2008). Generally, smokers should use at least nine per day in the first six months of therapy, and should be used for up to twelve weeks, with no more than twenty lozenges used per day (Center for Disease Control and Prevention, 2008). The two milligram is recommended for smokers that have the first cigarette more than thirty minutes after waking. The four milligram is used for patients that have the first cigarette within thirty minutes of waking (Center for Disease Control and Prevention, 2008). The most common side effects include nausea, dry mouth, hiccups, and heart burn. Use of the four milligram lozenges may also cause increased rates of headaches and coughing. The lozenge should be allowed to dissolve in the mouth rather than chewing or swallowing it (Center for Disease Control and Prevention, 2008).


Nasal spray-

The nicotine nasal spray produces higher peak nicotine levels than other nicotine replacement therapies (NRT) and has the highest dependency potential (Center for Disease Control and Prevention, 2008). A dose of the nasal spray consists of one 0.5 mg dose delivered to each nostril (1mg total). Initial dosing should be one spray per hour, increasing as needed for symptom relief (Center for Disease Control and Prevention, 2008). Minimum dosage is eight doses daily with a maximum of forty doses per day. Each bottle contains around one hundred doses. Recommended duration of therapy is three to six months (Center for Disease Control and Prevention, 2008). Patients should not sniff, swallow or inhale through the nose while administering doses, as this increases irritation. The spray is best delivered with the head slightly tilted back. Users report moderate to severe nasal irritation in the first two days of use. Nasal congestion and transient changes to taste and smell are also reported (Center for Disease Control and Prevention, 2008).


Nicotine patches

– treatment of eight weeks or less have been shown to be as effective as longer treatment periods (Center for Disease Control and Prevention, 2008). Patches of different doses are available. Dosing regimens should be based on patient characteristics such as amount smoked and degree of dependence (Center for Disease Control and Prevention, 2008). The step down dosage includes four weeks of twenty-one milligram per day patches, then two weeks of the fourteen milligram per day patches, then two weeks of the seven milligram per day patches (Center for Disease Control and Prevention, 2008). There is a single dose regimen available in twenty-two and eleven milligram per day patches for other step down regimens. Up to fifty percent of patients using the patch will experience a local skin reaction. These skin reactions are usually mild and self-limiting, but may be worsened during the course of therapy (Center for Disease Control and Prevention, 2008). Local treatment with a one percent hydrocortisone cream or a five percent triamcinolone cream, and rotation of patch sites may ease the skin irritation. Other side effects of the patches include insomnia and vivid or strange dreams. At the start of each day the patient should place a patch in a relatively hairless area, typically between the neck and waist, rotating the site daily to reduce irritation (Center for Disease Control and Prevention, 2008). The patch should be applied as soon as the patient wakes on the quit day. If insomnia is a problem, the patient should remove the patch prior to going to bed (Center for Disease Control and Prevention, 2008).


Varenicline

is an approved non-nicotine agent for smoking cessation (Center for Disease Control and Prevention, 2008)

.

The FDA added a warning regarding the use of this agent. Depressed mood, agitation, changes in behavior, suicidal ideation, and suicide have been reported in patients attempting to quit smoking when using Varenicline (Center for Disease Control and Prevention, 2008). Any history of psychiatric illness should be discussed before using this medication. Side effects of the medication include nausea, trouble sleeping, and abnormal or vivid dreams (Center for Disease Control and Prevention, 2008).

The patient should start Varenicline one week before the quit date, with a dose of 0.5 milligram daily for three days followed by 0.5 milligram twice daily for four days, followed by one milligram twice daily for three months. Varenicline is approved for maintenance therapy for up to six months (Center for Disease Control and Prevention, 2008). The patient should quit smoking on day eight, when the dosage is increased to one milligram twice daily. To reduce the insomnia problem, the second dose should be taken at dinner time rather than bedtime. To reduce the nausea, the medication should be taken on a full stomach (Center for Disease Control and Prevention, 2008).

Varenicline is a non-nicotine medication. The mechanism of action is due to its partial nicotine receptor agonist and antagonistic effects (Center for Disease Control and Prevention, 2008). Because Varenicline is eliminated almost entirely unchanged in the urine it should be used with caution in patients with severe renal dysfunction. It is not recommended to be used with other nicotine replacement therapies because of its nicotine antagonistic properties (Center for Disease Control and Prevention, 2008).


Plan of treatment

Patient will be advised that the increased cough and mucus production is related to the use of tobacco products and that once he no longer smokes the frequency of cough and mucus production will decrease as this is related to irritation in the lungs caused by tobacco use. A smoker’s cough is a persistent cough that develops in long-term smokers. At first it may be dry, but over time it usually produces phlegm. The cough is usually worst upon awakening and improves throughout the day. The airways are lined with tiny hair like cells called cilia, which catch toxins in inhaled air and move them upward toward the mouth to be expelled. Smoking paralyzes these cells. Instead of toxins being caught in transit, toxins enter the lungs and create inflammation. This leads to coughing as the lungs attempt to clear these toxins. As the Celia begins to repair themselves during the night and attempt to remove the accumulated substances from the lungs, the result is coughing upon arising. This cough will usually fade as the Celia is allowed to repair themselves from the abstinence of cigarette smoking.

Treatment will consist of smoking cessation counseling and support, Varenicline 0.5 mg daily, starting immediately, orally once daily for three days, then 0.5 mg orally twice daily for four days, followed by one mg orally twice daily for three months. Follow up should be in three days to evaluate side effects and patient response. The next follow-up will be dependent on patient progress and response to medication. The patient will be instructed on the community resources for smoking cessation support groups and how to cope with the stress of not smoking and how to manage daily frustrations related to smoking cessation. Dietary counsel will be offered for possible nutrition advice and weight management. The patient will be encouraged to enroll in an exercise program or to increase physical activities during the initial phase of smoking cessation. A chest x-ray will be ordered, at the patient’s convenience, to rule out COPD or other lung issues.

References

Brunton, L., Chabner, B., & Knollman, B. (2011).

Goodman & Gilman’s: The pharmacological basis of therapeutics

(12 ed.). McGraw-Hill.

Center for Disease Control and Prevention. (2008).

Clinical practice guidelines: Treating tobacco use and dependency

. Retrieved from CDC.gov:

http://www.bphc.hrsa.gov/buckets/treatingtobacco.pdf

Center for Disease Control and Prevention. (n.d.).

Smoking and tobacco use

. Retrieved from Center for disease control and prevention:

http://www.cdc.gov/tobacco/quit_smoking/how_to_quit/you_can_quit/nicotine

Research a healthcare organization and highlight how their policies align or misalign with the WHO’s definition of health.

Research a healthcare organization and highlight how their policies align or misalign with the WHO’s definition of health.

Why is the definition of health important to health policy?
Define the term “target population” as it relates to health policy.
How do societal influences impact the identification and definition process of policy?
Research a healthcare organization and highlight how their policies align or misalign with the WHO’s definition of health.

Role of Magnesium in Health and Disease Processes

Health concerns have become a fundamental issue in the 21

st

century. People around the world are taking a more active role in matters concerning their health. The internet is loaded with information that is geared towards educating people on making healthier choices. Many factors come into play for the effective functioning of the body organs. Electrolytes such as sodium, potassium, calcium and magnesium are minute and easily can be overlooked but the impact of a deficiency of one of them on the body can be fatal. There is a paucity of information available as concerns magnesium specifically. Most people are ignorant on the importance of this electrolyte and its interplay with human health and disease. Recent study findings indicate that the role of magnesium in health and diseases processes in the human body cannot be undermined. The study findings were published in the BMC Bioinformatics journal.

Chemical processes in the body are mediated by hormones and enzymes. Enzymes are protein compounds that act as catalyst or controls for the various reactions. The enzymes do not work in isolation and require various co factors for effectual working. Magnesium acts as a cofactor for over 300 enzymes in the human body. Of particular importance is the subset of enzymes that are tasked with regulating the process of energy (ATP) formation and utilization. The study revealed that human proteins contained binding sites for magnesium. This being the case, a deficiency of magnesium would therefore affect a wider range of biological processes.

The human DNA is the hereditary material that encodes genetic instruction used in the development and functioning of the human body. The DNA is responsible for synthesis of over 100,000 proteins. This is a highly specialized process. Each protein is coded for by a specific portion of DNA known as proteome. Recently discovered ‘magneseome’ is the portion of DNA that codes for the proteins that bind magnesium. Consequently, deficiency of magnesium will affect the synthesis of specific proteins in the body and have impact on health and disease.

In the recent past calcium has become a popular electrolyte supplement advocated for by nutritionists and clinicians with all effort geared to avoiding or combating calcium deficiency. Calcium garnered its popularity after an inaccurate definition of osteoporosis by WHO despite contrary research findings that showed that excess calcium in the body increases risk of heart disease and subsequent mortality.


Magnesium research.

Information gathered from magnesium related studies has build up over the last 40 years with each year having about 2000 study findings published. Cumulatively, magnesium has been shown to have over 100 health benefits. The article will highlight several key therapeutic uses for magnesium.


Fibromyalgia

: this is a chronic disorder that causes muscle pain, joint tenderness and fatigue. Deficiency of magnesium is a common feature of patients with fibromyalgia. Magnesium malate composed of low doses of magnesium (50mg) mixed with malic acid has been shown to provide relief for the muscle pain and joint tenderness when administerd to fibromyalgia patients.


Atrial fibrillation

: this is a disorder of heart rhythm and can be fatal. Study findings revealed that magnesium supplements decrease atrial fibrillation when used in isolation or together with other drugs.


Diabetes Type 2

: results from study conducted in 2007 found that 13.5-47.7% of patients with type 2 diabetes have magnesium deficiency. Long term complications of diabetes include peripheral neuropathy and coronary artery disease. Research has shown that patients with lower intracellular magnesium levels are likely to develop the fore mentioned complications. Oral supplementation with magnesium has been shown to be of immense benefit to patients. It results in reduction in fasting glucose, increasing levels of HDL, improving sensitivity to insulin and better metabolic control.


Premenstrual syndrome

: magnesium insufficiency has been found to be a common feature of women who suffer from premenstrual syndrome. Expectedly, magnesium has been shown to ease fluid retention, a common feature of premenstrual syndrome. In the course of a 3 month study period, women aged 18-45 were given 250mg of magnesium daily. The results showed that there was a roughly about a 34% reduction in symptoms associated with premenstrual syndrome. Together with vitamin B6, magnesium supplementation has been shown to alleviate premenstrual symptoms that are related to anxiety.


Cardiovascular disease and mortality

: low magnesium levels correspond to an increased risk of mortality from cardiovascular disease. Magnesium confers a protective effect on the cardiovascular system. It achieves this through various mechanisms. It lowers the blood pressure, it prevents spasms of the coronary arteries, it counters formation of clots within the blood vessels and acts as calcium channel blocker. Mitochondria are intracellular components that act as the site of energy production. The heart muscle is densely populated with mitochondria which require sufficient magnesium for ATP synthesis.


Migraine disorders

: the journal of Neural transmission recently published an article titled “why all migraine patients should be treated with magnesium”. The study found that the levels of magnesium in the body are not accurately reflected from routine investigations. This is because the bulk of magnesium is found in bone (67%) and that within the cells is 31%. Subsequently only 2% of body magnesium stores is in the extracellular space and this is what is picked up during investigations. The researchers advocated for empiric supplementation of magnesium in patients with migraines because lab results for magnesium levels in the body were unreliable. It has been demonstrated that magnesium supplementation orally reduces the incidence of headache days among children suffering from frequent migraine headaches. Magnesium used together with I-carnitine is effectual in reducing migraine frequency in adults.


Aging

: aging is a mandatory process of life. Magnesium insufficiency has been shown to hasten the rate of aging. This was clearly demonstrated among individuals who participated in extended space flight missions. Deficient magnesium levels in these individuals have been associated with accelerated aging of the heart tissue at a rate that is 10 times faster than normal. Neoroendocrine changes and sleep changes that are related to the natural process of aging can be reversed by magnesium supplementation. A possible explanation in which magnesium is able to undo the processes of aging is that it is essential for DNA stability and is essential during DNA replication.


Best sources of Magnesium in the diet.

Nature is generous to us. This is because magnesium is best sourced from food. Leafy green foods are good examples of dietary sources of magnesium. This is because they contain chlorophyll the pigment necessary for photosynthesis. Chlorophyll contains an atom of magnesium at its center. Without the atom of magnesium, the plant would not be able to employ the sunlight to synthesis energy. However elemental magnesium is colorless and foods that are not green contain it. After ingestion, magnesium is absorbed more effectively if combined with food cofactors than when it is in its elemental form.

The below listed foods are rich in magnesium. The list indicates how much magnesium would be sourced from a 100 grams serving of the corresponding food.

  • Crude rice bran(781mg)
  • Dried seaweed agar(770)
  • freeze-dried chives(640mg)
  • dried coriander leaf(694mg)
  • dried pumpkin seeds(535mg)
  • unsweetened dry cocoa powder(499mg)
  • dried basil(422mg)
  • flax seeds(392mg)
  • cumin seeds(366mg)
  • dried brazil nuts(376mg)
  • freeze dried parsley(372mg)
  • sesame seeds(346mg)
  • almond nuts butter(303mg)
  • roasted cashew nuts(273mg)
  • defatted soy flour(290mg)
  • dried sweet whey(176mg)
  • dehydrated bananas(108mg)
  • puffed millet(106mg)
  • freeze dried shallots(104mg)
  • freeze dried leeks(156mg)
  • raw salmon(95mg)
  • dehydrated onion flakes(92mg)
  • raw kale(88mg)

Magnesium supplement formulations are also available commercially. This will be of benefit to individuals who need higher doses of magnesium or those whose palates do not tolerate the fore mentioned foods. Taking glycine together with magnesium enhances absorption of the later increasing amounts available to the body. Stool softening and laxative properties are some extra benefits on magnesium therapy experienced when a person is taking magnesium citrate or oxide.

Evaluate the importance of monitoring the effect of technology on workflow.As you explored last week, the implementation of a new technology can dramatically affect the workflow of an organization.

Evaluate the importance of monitoring the effect of technology on workflow.As you explored last week, the implementation of a new technology can dramatically affect the workflow of an organization.
Discussion – Week 7

Collapse
Total views: 17 (Your views: 1)
Understanding Workflow Design

As you explored last week, the implementation of a new technology can dramatically affect the workflow of an organization. Newly implemented technologies can initially limit the productivity of users as they adjust to their new tools. Such implementations tend to be so significant that they often require workflows to be redesigned in order to achieve improvements in safety and patient outcomes. However, before workflows can be redesigned, they must first be analyzed. This analysis includes each step in completing a certain process. Some systems duplicate efforts or contain unnecessary steps that waste time and money and could even jeopardize patient health care. By reviewing and modifying the workflow, you enable greater productivity. This drive to implement new technologies has elevated the demand for nurses who can perform workflow analysis.

In this Discussion you explore resources that have been designed to help guide you through the process of workflow assessment.

To prepare:

Take a few minutes and peruse the information found in the article “Workflow Assessment for Health IT Toolkit” listed in this week’s Learning Resources.
As you check out the information located on the different tabs, identify key concepts that you could use to improve a workflow in your own organization and consider how you could use them.
Go the Research tab and identify and read one article that is of interest to you and relates to your specialty area.
Post on or before Day 3 a summary of three different concepts you found in “Workflow Assessment for Health IT Toolkit” that would help in redesigning a workflow in the organization in which you work (or one with which you are familiar) and describe how you would apply them. Next, summarize the article you selected and assess how you could use the information to improve workflow within your organization. Finally, evaluate the importance of monitoring the effect of technology on workflow.

Nhs Social Class Health Inequalities Health And Social Care Essay

The National Health Service has a lot of health inequalities regarding to people with gender, race and social class, this has become of interest to myself because there are a lot of issues that relate to the health inequalities of the National Health Service therefore I would be looking at the inequalities of the social class. For this I will be looking at how the NHS began and how the NHS has proceeded throughout the years. I will also be looking at how the government supports and funds the NHS. For the social class inequalities what health impacts there are between the upper and lower class, how private health care benefits those who receive private health care. How the Black Report provided evidence that there are health inequalities between social structure and how poverty affects the lower class.

The National Health Service was introduced in 1948, when health care sectary Aneurin Bevan (Labour) opened Park hospital in Manchester it bought plans for free good healthcare for all, this meant that for the first time all occupations of the healthcare came under one organisation such as nurses, doctors, dentists and opticians. With the approach of that good health care must be available to everyone regardless of the individuals’ wealth. It was the initial for anyone in the world to receive free health care on the basis of their citizenship not on fees. This came with the ideological perspective of that the health care system that all health care would be available to all and financed entirely from taxes, where people pay for the healthcare system according to their personal income.

The post war Labour Government took into place the NHS in 1948 as illnesses were soaring and thousands of people were dying from diseases which now could have been cured in today’s society these diseases included pneumonia and meningitis. Many of people suffered and tragically died because they could not afford to pay for treatment of healthcare or it was unavailable for numerous working class citizens.

Published in 1942 by William Beveridge, the Beveridge Report showed the need for dramatic change for the healthcare system. The report was designed to tackle the five giants of illness, poverty, disease, unemployment and unawareness in which Beveridge recommended the establishment of the National Health Service it recommended that the government should find ways to tackle ways of fighting the five giant evils.

Since 1948 when the National Health Service was born, the NHS has proven to be a success and fundamental to the society of the United Kingdom (UK). It has enabled families to go and seek medical advice in confidence, and receive treatment regardless of their financial background.

Since the NHS has been in place there has been a dramatic change throughout the 20th and 21st century life expectancy has increased from the average age of 45 years for men and 49 years for women in 1901 to over 75 years for men and over 80 years for women in 2006 – 2008. Also infant mortality has declined the chances of a baby surviving the first year of life has greatly decreased, according to the Office for National Statistics (ONS). However this is may be profound but the NHS has not exactly had the ‘smoothest’ of runs throughout the years, firstly with the conservatives opposing the NHS in 1948 then conservatives coming in and out of power throughout the years left years of neglect on the NHS, having lack of resources such as doctors, nurses and equipment. Labour having to somewhat reboot the NHS and make plans and changes to improve the inequalities and resources to the NHS.

The social democratic approach is to provide welfare state, which this consists of a view that social welfare is seen has a type of social citizenship, with the vision that social welfare is a basic right.

With the NHS being established by the post war labour government, it is usually associated with the social democratic approach having a more concern of social welfare, and focusing on the poor and working class citizens rather than focusing on the wealthier class citizens who can afford to pay for their own health care. The Beveridge Report was to tackle one of the ‘five giants’ illness and providing free health care to everyone still remains a key aspect of the Labour government.

There still is a lot of ideological issues in the NHS that still remain the nature of the provision, the NHS still remains free to everyone and is paid through national insurance (NI) and taxes which still tackles one of the five giants, illness. Where society has changed and life expectancy has increased and infant mortality has declined throughout the years.

Health Inequalities of the Social Class

Throughout the years there has been remarkable health improvements and social economic in the UK. People from all walks of life are living healthier and living longer in today’s society than ever before. Although this remains true there are still a lot of health inequalities that occur in the health care. This was established when a report published by Sir Douglas Black called ‘The Black Report’, showed evidence that health inequalities exist in the health care system, he based the report on mortality rates between social classes, ‘A method of comparing death rates between different sections of the population’ (Townsend and Davidson 1990). This also stimulated new research that social class as a key influence of people’s life chances.

With the National Health Service running for more than sixty years there is still a gap between social classes in all sections of societies applying to all aspects of health including life expectancy, infant and maternal mortality and the general level of health. With the gap between the social classes still emerging, there are still geographical differences between women and men; women tend to live longer by five years on average than men.

The social stratification suffers quite a significant gap within the health care system this may be because of the two tier system in the NHS where people who can afford to receive private health care treatment gives them the advantage of no queues meaning that they would not have to wait on waiting lists, where as the lower class who may not be able to afford private health care would have to wait to a maximum of 18 weeks between referral and treatment. For people who pay for private health care they are often to have a ‘choice’ where they can chose their own consultant and where they would like to be treated, unrestricted visiting hours, where as this may not apply towards lower class citizens because they cannot afford to go private.

The Black report does show evidence that there are health inequalities between social classes. For instance, life expectancy at birth for the upper class increased by six years over the last quarter of the 20th century, while infant mortality had risen by less than two years for the lower class by the end of the century (ONS, 2002). There is also double the infant mortality to the lower class compared to the upper class. Despite the improvements and changes that had been made in 1948 to suit all groups in the post war period. Statistics from the health sector has shown that the poor have shorter life expectancies and poorer health despite the Black Report.

Social class is ‘complex’ topic that involves status, wealth, culture, background and employment. There are a number of different influences of health, several of the health influences including social class. In 1943 Sigerist wrote, “The task of medicine is to promote health, to prevent disease, to treat the sick when prevention is broken down and to rehabilitate the people after they have been cured. These are highly social functions and we must look at medicine as basically a social science.” (Socialist Health Association)

The connection of social class and the health inequalities does not give very clear explanations of the reason why there is a gap between the social classes; people have many different variations of the cause. Such as the ‘Material Explanation’ where this explanation blames poverty, poor housing conditions, lack of resources in health and education as well as more dangerous occupations for the poor health in the lower social class. Poverty being a obvious cause towards ill health. Life expectancy is lower in less developed countries, but diseases that affect the developed world such as Britain tend to be diseases that are more self inflicted and can be avoided to an extend such as obesity, smoking and drinking alcohol to an extreme content. These tend to be more common occurrences for the poor or lower class than the more wealthier and upper class citizens.

The cultural explanation, propose that lower class citizens chose to have less healthier lifestyles, having unhealthy diets (eating fatty foods), smoke cigarettes, and drink a lot more alcohol than wealthy and upper class citizens. With healthier foods being more expensive than quick easy solution foods that contain a lot of unhealthy substances, this would be more of a priority than knowing what is healthier for them. People who work long shifts in factories or work all day tend not to seek any activities outside of work because they may not want to after working because of feeling too tired this does not give them adequate exercise for the cardio-respiratory system.

From the Black report that raised a lot questions to the health inequalities had lead to further reports, such as the Acheson Report that was published in 1998 by Sir Donald Acheson, a former chief medical officer. It found little cause for congratulation and also called for the issue of poverty to be addressed. The Acheson Report

In today’s society problems occur in poor healths which are related to obesity, smoking and the influence of alcohol and accidents. Where as in the past poor health was related to sanitation and infectious diseases. Although poverty is still a cause of poor health except poverty should not be equated to social class. Poverty can extend in variations and definitions of the word meaning ‘Poverty’, because it is very different to third world countries and those of the developed countries such as the UK. Poverty is going to affect the elderly and children more because they are most vulnerable and likely to be affected by poor health. Poverty is a real predicament. The Black Report and the Acheson Report both suggested trying to condense the inequalities of income in societies but these have grown instead. Social exclusion may be a result of poverty such as mental health and substance abuse.

Conclusion

The National Healthcare Service still remains to have the ideological perspective of free healthcare for everyone no matter what circumstances they are under or backgrounds as well as the healthcare being paid through taxation and national insurance, which the NHS still remains heavily funded by the taxation since 1948. Since the establishment of the NHS there has been dramatic change of life expectancy, infant and maternal mortality has dramatically improved since the early 19th century. The government and the public have acknowledged the value of the National Health Service which meets the peoples’ healthcare needs through taxation on the basis of citizenship rather than payment or contribution. Although this is a major improvement since the post war there still is a significant gap between the social classes for the National Health Service perhaps the greatest challenge for the government and the National Health Service is to focus on and address the problems of health and health inequalities of the service, with one of them being the health inequalities of social classes.

Throughout the assignment I perhaps had a political of the New Right theory and did not entirely believe in the NHS, however as I gathered research for my assignment I began to rethink my political view of the healthcare and the welfare system. I did not believe that people should be able to pay for private healthcare and get the ‘best’ and quickest treatment in the NHS itself. While people would have to wait for up to a maximum of 18 weeks, seems quite unfair. I believe that the NHS should be funded from taxation because if it was not then people would not be able to pay for healthcare it would be like taken back to the early 19th century where people died from diseases and illness because they could not afford to pay for treatment which could be easily treated in today’s society. With people still living in poverty today there are no major diseases or illnesses that can relate to death, with the only major health issues are mostly self inflicted causes such as smoking, substance abuse and obesity. Which all to some extend can be avoided.

Bibliography

http://www.nhs.co.uk/tools/documents/historyNHS.html

http://news.bbc.co.uk/1/hi/events/nhs_at_50/special_report/23511.stm

Collins, R. (unknown),”Proud of the NHS at 60″http://www.labour.org.uk/proud/labour_nhs accessed 22nd November 2009

School of Economics and political Science (2000), “The Beveridge Report and the Welfare State” http://www.lse.ac.uk/resources/LSEHistory/beveridge_report.htm accessed 22nd November 2009

(Unknown) (2009) “Life expectancy” http://www.statistics.gov.uk/cci/nugget.asp?ID=168 accessed 22nd November 2009

Homfray, M. (2009) Lecture Notes, Glyndwr University

http://www.bbc.co.uk/history/historic_figures/beveridge_williams.shtml

Unknown, 2009. “Health Inequalities” www.dh.gov.uk/en/Publichealth/Healthinequalities/index.htm accessed 22nd November 2009

Improving Health Practitioners Knowledge of Transgender Health Care

Improving Health Practitioners’ Knowledge of Transgender Health Care:

Measuring the Efficacy of the ECHO Project

Transgender (trans) is an umbrella term used to describe individuals with gender dysphoria. Gender dysphoria involves a conflict between a person’s assigned sex and gender at birth, and the gender in which a person identifies (Reisner, Radix, & Deutsch, 2016). There is currently no exact data on the number of trans people in Canada, however, it is estimated that 1 in 200 people in Ontario alone identify as trans (Scheim & Bauer, 2015). Many trans people undergo the process of gender affirmation, where trans individuals receive recognition and support of their gender identity and expression through social, medical, and legal approaches (Reisner, Radix, & Deutsch, 2016). In addition to unique gender-affirming health requirements, trans people also have primary and preventative health care needs that are similar to the general population (Safer et al., 2016). However, despite increasing social support, literature shows that the trans population continues to endure a variety of health disparities and lack access to adequate health care (Carabez, Eliason & Martinson, 2016).

Factors behind barriers to accessing health care in the trans population are multifaceted. Patient circumstances related to fear of discrimination and stigma, financial barriers surrounding hormone therapies and gender-affirming surgeries, and socioeconomic factors have been described in literature (Safer et al., 2016). Health systems issues, including inappropriate electronic records, forms, lab references, and inadequate clinic facilities have also been suggested  (Safer et al., 2016). However, among these barriers, research shows that the single largest component to inhibiting access to care is the lack of competent health care providers that are knowledgeable in trans health (Safer et al., 2016). Emerging studies suggest that integrating culturally competent trans health care into health professionals’ curriculum can improve knowledge, attitudes and overall trans health  (Yingling, Cotler & Hughes, 2016). However, trans-specific care is not taught in conventional curricula and remains to be a low priority for educational institutions (McDowell & Bower, 2017; Paradiso & Lally, 2018). In fact, many health care providers have acknowledged discomfort in caring for trans patients due to the lack of knowledge, resources, uncertainty, and fear (Paradiso & Lally, 2018). As a result, health practitioners continue to care for trans patients inadequately, while patients fear discrimination and encounters with practitioners who lack knowledge of their specific health care needs (Carabez, Eliason, & Martinson, 2016).

The consequences of barriers described have resulted in a lack of access not only to trans-specific care, but also to primary and preventative health services, resulting in the delayed treatment of routine health issues (Safer et al., 2016). For example, a recent study completed at St. Michael’s Hospital in Toronto reported that screening rates for cervical, breast and prostate cancer are extremely low for the trans population (Kiran et al., 2019). The study found that trans patients were 70% less likely to be screened for breast cancer, 60% less likely to get tested for cervical cancer, and 50% less likely to be screened for colorectal cancer (Kiran et al., 2019). Patients who have transitioned through hormone therapy and gender-affirming surgeries are also found to have misconceptions regarding their heath care needs, and thus require better guidance from knowledgeable health practitioners (Kiran et al., 2019; Vogel, 2014). There is therefore a call for research to be conducted to further determine the gaps in knowledge and biases of current health practitioners, and a specific need to determine whether health providers receive adequate training in trans care (Safer et al., 2016). Researchers in support of improving access to trans care call on health providers to further determine gaps in knowledge, assist in generating solutions, and validate the effectiveness of proposed solutions (Safer et al., 2016)

As an answer to the call on improving health provider knowledge and trans health care access, the Centre for Addiction and Mental Health and the University of Toronto launched the ECHO Project in May 2018. The ECHO Project is a knowledge translation method that connects health care providers in rural and underserved areas across Canada with experts on trans and gender diverse health care. The project consists of eight online videoconference sessions that are aimed at improving the knowledge and skills of allied health practitioners in order to reduce disparities and improve health care access for trans patients (Centre for Addiction and Mental Health [CAMH], 2018). The sessions are free for all interdisciplinary healthcare professionals and require only a commitment of active involvement in the peer learning community through sharing of experiences and presentation of cases (CAMH, 2018).

In a multicultural society such as Canada, it is imperative that health practitioners practice cultural competence care in their care. Culturally competent care is the ability of health care providers to effectively deliver care that meet the social and cultural needs of all patients (Canadian Nurses Association [CNA], 2010).  It is a nursing standard and a component of quality practice environments that contributes to overall improved health outcomes (CNA, 2010). Given their large presence across systems of health care, nurses are uniquely positioned to alleviate the barriers faced by trans people, and are integral to creating environments that promote and integrate culturally competent trans health care (Yingling, Cotler & Hughes, 2016).

The ECHO project is a promising tool that combats the barriers to health care access by addressing the lack of knowledge and increasing the capacity of health practitioners when providing trans health care. However, its efficacy has yet to be determined. It is important to determine the validity of solutions in order to measure its adequacy and effectiveness so that wasted resources may be reduced, and further improvements can be made. The purpose of this study is to therefore determine the efficacy of the ECHO Project in increasing health provider knowledge and competency, thus improving access to and the delivery of trans health care.


References


  • Canadian Nurses Association. (2010). Promoting cultural competence in nursing. Retrieved from

    https://www.cna-aiic.ca/-/media/cna/page-content/pdf-en/6—

    ps114_cultural_competence_2010_e.pdf
  • Carabez, R. M., Eliason, M. J., & Martinson, M. (2016). Nurses’ knowledge about transgender patient care: A qualitative study.

    Advances in Nursing Science, 39

    (3), 257-271. doi:10.1097/ANS.0000000000000128
  • Centre for Addiction and Mental Health. (2018).

    ECHO Ontario trans and gender diverse health


    – supporting clients with medical and surgical transitions

    .               Retrieved from https://camh.echoontario.ca/trans-health/
  • Kiran, T., Davie, S., Singh, D., Hranilovic, S., Pinto, A. D., Abramovich, A., & Lofters, A. (2019). Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.

    Canadian Family Physician Medecin De Famille Canadien, 65

    (1), e30.
  • McDowell, A., & Bower, K. M. (2016). Transgender health care for nurses: An innovative approach to diversifying nursing curricula to address health inequities.

    The Journal of Nursing Education, 55

    (8), 476-479. doi:10.3928/01484834-20160715-11
  • Paradiso, C., & Lally, R. M. (2018). Nurse practitioner knowledge, attitudes, and  beliefs when caring for transgender people.

    Transgender Health, 3

    (1), 47-56. doi:10.1089/trgh.2017.0048
  • Reisner, S. L., Radix, A., & Deutsch, M. B. (2016). Integrated and gender-affirming transgender clinical care and research.

    JAIDS Journal of Acquired Immune Deficiency Syndromes, 72 Suppl 3

    , S235-S242. doi:10.1097/QAI.0000000000001088
  • Safer, J.D., Coleman, E., Feldman, J., Garofalo, R., Hembree, H., Radix, A., & Sevelius, J. (2016). Barriers to health care for transgender individuals.

    Current Opinion in Endocrinology, Diabetes and Obesity, 23

    (2), 168-171. doi: 10.1097/MED.0000000000000227
  • Scheim, A. I., & Bauer, G. R. (2015). Sex and gender diversity among transgender persons in Ontario, Canada: Results from a respondent-driven sampling survey.

    The Journal of Sex Research, 52

    (1), 1-14. doi:10.1080/00224499.2014.893553
  • Vogel, L. (2014). Screening programs overlook transgender people.

    CMAJ: Canadian Medical Association Journal = Journal De l’Association Medicale Canadienne, 186

    (11), 823-823. doi:10.1503/cmaj.109-4839
  • Yingling, C. T., Cotler, K., & Hughes, T. L. (2017). Building nurses’ capacity to address health inequities: Incorporating lesbian, gay, bisexual and transgender health content in a family nurse practitioner programme.

    Journal of Clinical Nursing, 26

    (17-18), 2807-2817. doi:10.1111/jocn.13707

NRNP 6635 FINAL EXAM WEEK 11 – QUESTION AND ANSWERS (2021)

Description

NRNP 6635/NRNP 6635F 9-Psychpathology Diag Reasoning Week 11 Final Exam (2021)
1. Select the mental function that is most affected in mild cognitive impairment.
2. Select the most frequent cause of infant and childhood intellectual disability that is attributed to a specific gene.
3. Select the neurotransmitter that is most associated with the occurrence of ADHD.
4. Select the drug of choice to treat psychosis in delirious patients.
5. Select the characteristic that is greater in childhood than adult onset schizophrenia.
6. Select the personality disorder in which patients are continually in crisis and exhibit unpredictable behavior.
7. Select the factor that best correlates with attempted and completed suicide.
8. Select the brain region that shows the greatest anatomical abnormalities in schizophrenic patients.
9. Select the gender dysphoria in which genital surgery is usually not chosen.
10. Select the antipsychotic drug for which the labeling carries a black box warning for agranulocytosis.
11. Select the time of onset for tolerance to develop from continuous use of hallucinogens such as LSD.
12. Select the most reliable method to make a diagnosis of schizophrenia.
13. Select the dysfunction that is common to 50% to 85% of schizophrenic patients.
14. Select two of the “Four A’s” symptoms of schizophrenia described by Bleuler.
15. Select the personality disorder in which patients exhibit covert obstructionism, procrastination and pessimism.
16. Select the negative symptom of schizophrenia.
17. Select the main cause of female orgasmic disorder.
18. Select the age range for 90% of patients treated for schizophrenia.
19. Select the non-drug therapy in which mastery of anxiety through desensitization is critical to the successful treatment of sexual dysfunction.
20. Select the disorder that is often comorbid with a brief psychotic disorder.
21. Select the psychoactive substance that is most frequently consumed worldwide.
22. Select the age range at which most children with gender dysphoria begin to show increased anxiety over anticipated changes to their bodies.
23. Select the theorist who first studied social and cultural influences on suicide.
24. Select the disorder in which is characterized by a lack of breast development.
25. Select the age range of the highest rate of substance dependence or abuse.
26. Select two terms preferred to describe sexual orientation.
27. Select the two patient populations in which delirium occurs most frequently.
28. Select the drug used to treat the neuroleptic malignant syndrome.
29. Select the drug that is most likely to cause parkinsonian movement symptoms.
30. Select the two main conditions to initially identify in adult psychiatric emergencies.
31. Select the psychiatric emergency that is indicated by mothers who express inadequate distress over their children’s medical symptoms.
32. Select the drug that is least life-threatening when consumed in an overdose.
33. Select the drug that is most safe and effective in treating mild to moderate memory loss in early Alzheimer’s disease.
34. Select the substance that is most commonly abused by adolescents.
35. Select the development time of symptoms in neuroleptic malignant syndrome.
36. Select the patient population at most risk of mortality from delirium.
37. Select the most distinguishing characteristic of delirium.
38. Select the category of symptoms that is most commonly comorbid with cognitive disorders.
39. Select the primary defense mechanism that is common in delusional disorder.
40. Select the neurotransmitter system that is most associated with the addictive rewarding properties of opioids.
41. Select the type of hallucinations most common in schizophrenia.
42. Select the diagnostic criterion for catatonia resulting from a medical condition.
43. Select the two factors that are not applicable to diagnosing schizoaffective disorder.
44. Select the percentage of substance-addicted persons with a concurrent psychiatric disorder.
45. Select the hepatic enzyme that performs the initial metabolism of alcohol.
46. Select the epidemiologic characteristic of tardive dyskinesia symptoms.
47. Select the neurotransmitter that inhibits sexual orgasm.
48. Select the drug that is least likely to cause male sexual dysfunction.
49. Select the youngest age at which childhood-onset schizophrenia can be distinguished from autism spectrum.
50. Select the most effective form of questioning when taking a sex history.
51. Select the initial intervention to treat children experiencing acute school refusal.
52. Select the primary method to assess cognition.
53. Select the preferred drug used to treat alcohol withdrawal.
54. Select the procedure most applicable to confirming a diagnosis of delirium.
55. Select the brain region that is associated with substance addiction.
56. Select the two defense mechanisms used commonly by patients with personality disorders.
57. Select the lifetime prevalence of schizophrenia in the United States.
58. Select the subtype of schizophrenia in which auditory hallucinations are frequent.
59. Select the neurotransmitter deficiency that is most associated with delirium.
60. Select the rating scale used to assess medication-induced movement disorders.
61. Select the symptom not present in paranoid personality disorder.
62. Select the percentage range of schizophrenic patients that remain significantly impaired throughout their lives.
63. Select the drug most likely to inhibit female orgasm.
64. Select the two non-drug therapies most likely to be effective in treating paraphilic disorders.
65. Select the two patient populations most likely suffer neuroleptic-induced parkinsonian symptoms.
66. Select the factor that is most influential in determining gender role development.
67. Select the most common paraphilic disorder.
68. Select the therapy that is contrary to position statements of the American Academy of Child and Adolescent Psychiatry.
69. Select the psychiatric disorder in which patients refuse mental health care and deny their problems.
70. Select the most common cause of dementia in elderly persons.
71. Select the substance of abuse with the strongest evidence for genetic association.
72. Select the characteristic found in persons with intersex conditions.
73. Select the medical condition in which erectile dysfunction drugs (e.g., sildenafil) are likely to be ineffective.
74. Select the neurotransmitter that increases sexual desire.
75. Select the infectious disease that when untreated may lead to an incorrect diagnosis of depression.
76. Select the two essential features of sexual dysfunction.
77. Select the personality disorder in which patients seek social withdrawal.
78. Select the percentage of the U.S. population with a substance dependence problem as of year 2012.
79. Select the youngest age by which early-onset schizophrenia occurs.
80. Select two psychiatric disorders that are often misdiagnosed as childhood-onset or early- onset schizophrenia.
81. Select the comorbid disorder that is more frequent in children with gender dysphoria.
82. Select two treatments for adults who identify as transgender.
83. Select two comorbid factors common in schizophrenic patients.
84. Select the age at which sexual identity is self-evident.
85. Select the pair of terms that represents the greatest conflict regarding sexual behavior.
86. Select the two characteristics that describe normal sexual behavior.
87. Select the medical condition that occurs less frequently in schizophrenic patients than in the general population.
88. Select the most frequently abused illicit drug.
89. Select the two drugs used to treat alcohol dependence.
90. Select the percentage of remission that results from correct antipsychotic drug therapy of schizophrenic patients.
91. Select the percent blood alcohol level at which voluntary motor activity becomes impaired.
92. Select the drug most likely to be effective treating paraphilic disorders.
93. Select the most distinguishing feature in the course and prognosis of schizophrenia.
94. Select the personality disorder in which patients are preoccupied with perfectionism and interpersonal control.
95. Select the rare adverse effect of SSRI antidepressants.
96. Select the neurotransmitter for which the metabolite 5-HIAA in CSF is evident and predictive of suicide.
97. Select the two behaviors of schizophrenic patients that occur more frequently than in the general population.
98. Select the neurotransmitter that has least involvement in drug-induced movement disorders.
99. Select the factor that exerts the strongest influence on the initiation of substance use disorder in adolescents.
100. Select the intrinsic chemical released in orgasm that reinforces pleasurable sensation.

Diabetes Mellitus and Hypercalcaemia Case Study


ABSTRACT

We report a case of diabetes mellitus in a middle aged female who developed primary hyperparathyroidism and had parathyroidectomy. She had multiple hospitalizations for vomiting, pain abdomen and dehydration. Hypercalcaemia was never documented though. She developed pancreatic calcification later, was diagnosed as FCPD (Fibrocalculupancreatic diabetes) and treated with insulin. In the next hospitalization, nephrolithiasis, hypercalcaemia and high PTH (parathormone) levels were detected. A solitary parathyroid adenoma was identified and surgically removed. Gastrointestinal symptoms disappeared but diabetes remained unaltered



keywords:



Diabetes, Hypercalcaemia, Parathyroid adenoma


INTRODUCTION

Pancreatic calcification is a well recognized cause of diabetes but development of primary hyperparathyroidism in the background of pancreatic and renal calcification and diabetes is uncommon. Solitary parathyroid adenomas are the commonest cause of primary hyperparathyroidism. Primary hyperparathyroidism classically presents with fractures, kidney stones, depression, hypertension and peptic ulcer disease, predominantly in females. Clinical presentation of primary hyperparathyroidism is changing and most cases are now picked up during evaluation of other conditions. We report a case of primary hyperparathyroidism who presented with gastrointestinal symptoms followed by multiorgan calcification and then diabetes and finally life threatening hypercalcaemia..


CASE REPORT

Mrs. T C, 51 –year-old female had recurrent episodes of vomiting with dehydration necessitating multiple (2 to 3 times every year) episodes of hospitalization since 1988. No surgical cause could be identified. Initial investigations in 1988 revealed plasma glucose, calcium, phosphorus, liver function tests, serum amylase, lipase all within normal limits. Ultrasonography of pancreas, upper GI endoscopy and CT scan of abdomen were normal.

The patient developed diabetes in 1991, during the course of a hospital admission. Her serum amylase level was 47 iu/l (within normal range); sonography of the abdomen showed pancreatic calcification and a CT scan showed pancreatic calcification with dilated pancreatic duct, intraductal calculi and atrophic pancreas suggestive of chronic pancreatitis. From 1993 the intensity and frequency of episodic vomiting and pain abdomen increased, occurring every 3-4 months and relieved gradually over 3-4 days with iv fluids and conservative management.

In 2003 she was hospitalized with urinary tract infection and was found to have hypertension and bilateral nephrolithiasis. At that time, her diabetes was poorly controlled (FPG : 230 mg/dl, PPPG : 245 mg / dl), normal renal profile (urea : 25 mg/dl, creatinine : 0.86 mg/dl) and normal serum calcium (9.12 mg /dl). She was discharged after stabilization with insulin.

In December 2004, she was admitted to hospital with similar symptoms along with severe hyperglycaemia (365mg/dl). Investigations revealed, no ketone bodies in urine, normal amylase (29 iu/l) and lipase (14 iu/l ). There were multiple areas of calcification in pancreas, spleen, kidneys on sonography. Her renal profile was normal (Urea : 44 mg / dl, Creatinine : 1.2 mg/dl) with severe hypercalcaemia (serum calcium : more than 15 mg/dl) and normal serum phosphorus (4.7 mg/dl) and albumin (4.0 gm/dl ).

Initially hypercalcaemia was treated with iv saline and oral alendronate. Her calcium came down to 9.4mg/dl and phosphorus came to 0.6mg/dl and then the latter stabilized at 10mg/dl and 3.44mg/dl respectively. Her serum PTH level was high at 221.7 pg/ml (normal range : 11–79.5pg/ml), obtained at a time when serum calcium had normalized at 10.0 mg/dl. She was advised a parathyroid sestamibi scan which showed a right inferior parathyroid adenoma.

The patient underwent right inferior parathyroidectomy. Histology confirmed a parathyroid adenoma. Following parathyroid surgery her gastrointestinal symptoms disappeared but diabetes persisted and required insulin. Her serum calcium and phosphate levels were normal (Ca : 8.58 mg/dl & PO4 : 3.54 mg/dl) with oral calcium : 1.5gm daily and Calcitriol : 0.5ug daily.

She was further evaluated for MEN1, but no pituitary pathology was seen on CT scan. She is on regular follow up till March 2012 and requires insulin treatment regularly for control of the persistent hyperglycemic state.


DISCUSSION

Primary hyperparathyroidism (PHPT) has a variable clinical expression. The clinical profile of the disease in West has changed from that described in the past but symptomatic PHPT is still the predominant form of the disease in many parts of the world, especially developing countries .

1

PHPT in Indians is a severe, symptomatic disorder with skeletal, muscular and renal manifestations at a younger age.

2

Our patient presented with gastrointestinal symptoms first (1988), pancreatic calcification & diabetes (1991 ) second, nephrolithiasis (2003) third and life threatening hypercalcaemia (2004) at the last. Intermittent hypercalcaemia is a recognized biochemical finding of PHPT

3

and often require very sophisticated diagnostic tools (parathyroid venous sampling and bone densitometry) to identify the cause

4

at this early stage of the disease. Intermittent hypercalcaemia may be the cause of repeated attacks of vomiting and pain abdomen in the initial years.

Intermittent hypercalcaemia may produce multiorgan calcification including kidney

5

before development of symptomatic hypercalcaemia. Parathyroid adenoma may lead to pancreatic calcification

6

and PHPT leading to pancreatic calcification can give rise to diabetes.

7

Increased prevalence of diabetes mellitus (DM) and glucose intolerance in primary hyperparathyroidism (PHPT) is established by many studies.

8,9

The prevalence of diabetes mellitus in primary hyperparathyroidism is approximately 8% and that of primary hyperparathyroidism in diabetic patients is approximately 1%. Both values are about three-fold higher than the respective expected prevalences in general populations.

10

In our given case diabetes and pancreatic calcification developed early (in 1991 ) and hypercalcemia with PHPT discovered 13 years later (in 2004).

The response of parathyroid surgery on diabetes is variable : diabetic condition improves or cured in some patients,

10

remain unaltered in another some and some patients experienced a deterioration of their glucose tolerance.

11

Diabetic state of our given patient remained unaltered following parathyroid surgery. The type of diabetes associated with PHPT is also variable. Type1 or Type 2

10,13

or may be a secondary diabetes from pancreatic calcification.

7

A diagnosis of chronic calcific pancreatitis (CCP) was established in this patient by evidence of characteristic abdominal pain; presence of diabetes mellitus and radiological evidence of pancreatic calculi.

12

MEN : MEN1 is characterized by the combined occurrence of tumors of the parathyroid, pancreatic islet cells and anterior pituitary. Parathyroid tumors occur in 95% of MEN1 patients and the resulting hypercalcaemia is the first manifestation in about 90% of patients. Though no neoplastic changes was identified in pituitary or pancreatic region of the patient, a close follow up necessary to detect such changes in future.

MEN2 describes the association of medullary thyroid carcinoma , pheochromocytomas and parathyroid tumors. Medullary thyroid carcinoma is the commonest component in MEN2. The patient had no goitre and serum calcitonin level could not be estimated.


CONCLUSION

Hyperparathyroidism may not be associated with persistent hypercalcaemia, but rather present as intermittent or episodic high serum calcium levels. Our case study underlines the importance of considering hypercalcaemia if a patient presents with recurrent GI (gastrointestinal) symptoms. Hypercalcaemia may also lead to multiple organ calcifications. The high Ca (calcium) levels and GI symptoms may resolve with parathyroidectomy, but the irreversible diabetes persists.


REFERENCES

1.

Bhansali A

,

Masoodi SR

,

Reddy KS

, et al. Primary hyperparathyroidism in North India: A description of 52 cases.

Ann Saudi Med.

2005; 25(1):29-35.

2.

Mishra SK

,

Agarwal G

,

Kar DK

, et al. Unique clinical characteristics of Primary hyperparathyroidism in India.

Br J Surg.

2001; 88(5):708-14.

3.

Broadus AE

,

Horst RL

,

Littledike ET

, et al. Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and simple diagnosis by means of an oral calcium tolerance tests.

Clin Endocrinol (Oxf).

1980; 12(3):225-35.

4.

Barilla DE

,

Pak CY

. Pitfalls in parathyroid evaluation in patients with calcium urolithiasis.

Urol Res.

1979; 7(3):177-82.

5.

Ljunghall S

,

Kallsen R

,

Backman U

, et al. Clinical effects of parathyroid surgery in normocalcaemic patients with recurrent renal stones.

Acta Chir Scand.

1980; 146(3):161-9.

6. Stone GR. Pancreas and parathyroid. Parathyroid adenoma in association with pancreatic calcification.

J Kans Med Soc.

1962 Dec; 63:519-21.

7.

Kubota S

,

Yamada Y

,

Wakasugi H

, et al. An autopsy case of renal failure as its cause of death in a patient with primary hyperparathyroidism associated with chronic pancreatitis. Fukuoka Igaku Zasshi. 1996; 87(10):226-8.

8. Taylor WH. The prevalence of diabetes mellitus in patients with hyperparathyroidism and among their relatives. Diabet Med 1991; 8: 683-687.

9.

Khaleeli AA

,

Johnson JN

,

Taylor WH

. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.

Diabetes Metab Res Rev.

2007; 23(1):43-8.

10.

Taylor WH

,

Khaleeli AA

. Coincident diabetes mellitus and primary hyperparathyroidism.

Diabetes Metab Res Rev.

2001; 17(3):175-80.

11.

Ljunghall S

,

Palmer M

,

Akerstrom, G

et al. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy.

Eur J Clin Invest.

1983; 13(5):373-7.

12.

Balaji LN

,

Tandon RK

,

Tandon BN

, et al. Prevalence and clinical features of chronic pancreatitis in southern India.

Int J Pancreatol.

1994; 15(1):29-34.

NURS 693B Assignment LinkedIn Professional Profile

NURS 693B Assignment LinkedIn Professional Profile

 

NURS 693B Assignment LinkedIn Professional Profile

Your completed LinkedIn
profile is due this week. It is the program expectation that you have developed
a comprehensive and evolving networking tool that can be used throughout your
career. Please remember that you may accomplish all of the assignment criteria
using the free account. You are not required to purchase a premium account. The
level of privacy you assign to your LinkedIn account is up to you. Visit Account
& Settings to manage your account privacy.

Review the Getting
Started With LinkedIn module on the main menu if needed.

You can print out the
list of required items here.

List of required LinkedIn items Click for more options

Submit the URL link to
your LinkedIn profile to the assignment dropbox for evaluation. To get the URL,
you must:

Click on the arrow under
your picture that says “Me” in the top right corner of of LinkedIn.

Click on the blue link
that says view profile.

Click on edit your public
profile on the right side of the screen.

This will show your
assigned LinkedIn URL. You may edit it if you like.

It is recommended that
you also include this URL on your resume/CV once your profile is complete.

Required Professional Profile Items

A professional photo linked to the account

A professional written bio

ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS:NURS 693B Assignment LinkedIn Professional Profile

Your professional nursing philosophy

A complete and current employment history

A complete and current curriculum vitae

A complete and current education/academic history

Copies of certificates

Professional and personal references (3 or more)

A minimum of one showcase project from your WCU
program (one media or written assignment that showcases your best work)

A list of volunteer and/or intern/practicum experience

All contact information

Include the following, if relevant

Language
skills

A list of related organizations and affiliations

A list of honors and awards

Other

Optional

Test scores and/or upload transcripts

Additional exemplary course work beyond the minimum
requirement

Affiliations or causes that extend beyond your
nursing career

Personal details

Published articles

Get a
10 % discount on an order above
$ 80